Data / Form D filings / SEQUENOM INC
SEQUENOM INC: Form D filings
SEQUENOM INC, a biotechnology company in San Diego, United States, filed 4 Form D notices with the SEC between 2009 and 2015. The latest, on June 19, 2015, reports $85 million sold of a $85 million offering to 10 investors.
Find out what SEQUENOM INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3595 JOHN HOPKINS COURT, San Diego, United States, 92121
- Phone
- (858) 202-9000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1076481
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 19, 2015 | New notice | $85,000,000 | $85,000,000 | $0 | 10 | Jun 9, 2015 | sec.gov |
| Sep 24, 2012 | New notice | $130,000,000 | $130,000,000 | $0 | 2 | Sep 17, 2012 | sec.gov |
| May 24, 2010 | New notice | $51,605,250 | $51,605,250 | $0 | 18 | May 17, 2010 | sec.gov |
| Dec 29, 2009 | New notice | $1,512,015 | $1,512,015 | $0 | 27 | Dec 21, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard A. Lerner | Director | |
| Carolyn F. Beaver | Executive Officer | |
| Daniel S. Grosu | Executive Officer | |
| Myla S. Lai-Goldman | Director | |
| John A. Fazio | Director | |
| Charles M. Slacik | Director | |
| Kenneth F. Buechler | Director | |
| William S. Welch | Executive Officer, Director | |
| David M. Pendarvis | Director | |
| Dirk van den Boom | Executive Officer, Director | |
| Ronald M. Lindsay | Director | |
| Robin S. Weiner | Executive Officer | |
| Jeff M. Linton | Executive Officer |
Every Form D from the week of Jun 15, 2015 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SEQUENOM INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.